dc.contributor.author | Peletidi, Aliki | |
dc.contributor.author | Charalambous, Pericles | |
dc.contributor.author | Papavramidis, Panagiotis | |
dc.contributor.author | Petrou, Christos | |
dc.contributor.author | Manesis, Nikolaos | |
dc.date.accessioned | 2021-04-20T08:03:25Z | |
dc.date.available | 2021-04-20T08:03:25Z | |
dc.date.issued | 2018-06 | |
dc.identifier.issn | 2155-9880 | |
dc.identifier.uri | http://hdl.handle.net/11728/11936 | |
dc.description.abstract | Statement of the Problem: Cardiovascular disease (CVD) is the main killer, associated
with 31% of all deaths in 2015 worldwide. In Cyprus, the mortality caused by CVD
reached 38% in the same year. Specifically, in women CVD caused 52% of deaths and
in men 55.4%. Pharmacists are one of the most accessible healthcare professionals
(HCPs) and the first port of call for the general public. Therefore, pharmacists can
have a key position in the prevention of CVD. Interestingly, another reason why
pharmacists and most specifically Cypriot pharmacists could play a vital role in CVD
prevention is the fact that there are 55.59% pharmacies per 100.000 inhabitants. The
aforementioned classifies Cyprus as the second country among Europe which has this
amount of pharmacies based on the PGEU report 2015. Our study aimed to explore
the existing and the possible future role of Cypriots pharmacists in CVD prevention
but also to identify any barriers that pharmacists may have as well as to detect their
needs for their future role and their preferences of delivering public health services.
Methodology & Theoretical Orientation: This study used qualitative research
methods utilizing semi-structured interviews with Cypriot pharmacists from the two
largest cities, Nicosia and Limassol. Purposive sampling was used, with pharmacists
randomly selected through a table of random numbers. The sample size was not
predetermined and interviews were continued until data saturation was reached. The
total number of interviews conducted was 15. The interview schedule was comprised
of 27 open-ended questions including demographic information. The first section of
the interview dealt with the primary prevention of CVD, the second contained
general questions about the role of the pharmacist in the prevention of CVD and
finally the third part included the demographic information. Prior to the data analysis
interviews were transcribed verbatim and translated into English.
Results: The analysis of the data was conducted using thematic analysis process. Four
themes were arising: (1) pharmacist's perceptions about their role, (2) pharmacist's
knowledge and education, (3) pharmacist's communication and relationship and (4)
barriers. Pharmacists are keen to initiate and deliver public health services with the
majority stating that pharmacy-led hypertension screening service should be the first
one. Furthermore, an interesting point was that pharmacists expressed the need for a
structured approach through the Cypriot Pharmaceutical Association and the
Department of Health.
Conclusion & Significance: This is the first study exploring Cypriot pharmacist's views
on their role in CVD prevention. Pharmacists have the potential to actively participate
in CVD prevention. They expressed the need to move forward by offering public
health services but also, they indicated that the Cypriot National Health System
should allow them to have a more active role and to incorporate them in the primary
care system with an equal role compared with other HCPs | en_UK |
dc.language.iso | en | en_UK |
dc.publisher | Journal of clinical & experimental cardiology | en_UK |
dc.relation.ispartofseries | 3rd International Conference on Cardiovascular Medicine and Cardiac Surgery; | |
dc.relation.ispartofseries | 26th Annual Conference on Clinical & Medical Case Reports in Cardiology; | |
dc.relation.ispartofseries | ;vol. 9 | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | en_UK |
dc.title | The first study exploring pharmacist's perceptions about their role in CVD prevention in Cyprus | en_UK |
dc.type | Article | en_UK |
dc.doi | DOI: 10.4172/2155-9880-C6-104 | en_UK |